Symptomatology and pathogenesis of different types of pain in multiple sclerosis

Neurologia i Neurochirurgia Polska

Volumn 48, Issue 4, 2014, Pages 272-279

  Brola, Waldemar ^a   Mitosek Szewczyk, Krystyna ^b   Opara, Józef ^c  

^a Department of Vascular Surgery and Angiology   (Poland)

^b MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^c INSTITUTE OF SPORT SCIENCES   (Poland)

Author keywords

Chronic pain; Health related quality of life; Multiple sclerosis; Neuropathic pain

Indexed keywords

AMITRIPTYLINE; BOTULINUM TOXIN; CANNABINOID; CARBAMAZEPINE; CORTICOSTEROID; DULOXETINE; GABAPENTIN; INTERFERON; LAMOTRIGINE; LIDOCAINE; MEXILETINE; NORTRIPTYLINE; PHENYTOIN; PREGABALIN; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROIC ACID; VENLAFAXINE;

CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL (TOPIC); CRYOTHERAPY; DEMYELINATION; DISEASE CLASSIFICATION; ELECTROSTIMULATION THERAPY; HEADACHE; HUMAN; HYDROTHERAPY; LHERMITTE SIGN; LIMB DYSESTHESIA; LOW BACK PAIN; MIGRAINE; MULTIPLE SCLEROSIS; MUSCULOSKELETAL PAIN; MYOTONIA; NERVOUS SYSTEM INJURY; NEUROPATHIC PAIN; PATHOPHYSIOLOGY; PSYCHOGENIC PAIN; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROBULBAR OPTIC NEUROPATHY; REVIEW; SPASTICITY; TRIGEMINUS NEURALGIA;

CHRONIC PAIN; HEALTH-RELATED QUALITY OF LIFE; MULTIPLE SCLEROSIS; NEUROPATHIC PAIN;

DISEASE PROGRESSION; HUMANS; MULTIPLE SCLEROSIS; NEURALGIA; PREVALENCE;

EID: 84906821708     PISSN: 00283843     EISSN: 18974260     Source Type: Journal    
DOI: 10.1016/j.pjnns.2014.07.009     Document Type: Review

References (69)

1. Selmaj K. Stwardnienie rozsiane. Poznań: Wydawnictwo Medyczne Termedia; 2006.
2. Fryze W, Zaborski J, Członkowska A. Ból w przebiegu stwardnienie rozsianego. Neurol Neurochir Pol 2002;36:275-84.
3. O'Connor AB, Schwid SR, Herrmann DN, Markman JD, Dworkin RH. Pain associated with multiple sclerosis: systematic review and proposed classification. Pain 2008;137(1):96-111.
4. Kalia LV, O'Connor PW. Severity of chronic pain and its relationship to quality of life in multiple sclerosis. Multiple Scler 2005;11(3):322-7.
5. Svendsen KB, Jensen TS, Hansen HJ, Bach FW. Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 2005;114(3):473-81.
6. Warnell P. The pain experience of a multiple sclerosis population: a descriptive study. Axone 1991;13(1):26-8.
7. Hadjimichael O, Kerns RD, Rizzo MA, Cutter G, Vollmer T. Persistent pain and uncomfortable sensations in persons with multiple sclerosis. Pain 2007;127(1-2):35-41.
8. Potemkowski A. Ból ośrodkowy - mózgowy i rdzeniowy. Pol Przegl Neurol 2007;3(4):249-53.
9. Beiske AG, Pedersen ED, Czujko B, Myhr K-M. Pain and sensory complaints in multiple sclerosis. Eur J Neurol 2004;11(7):479-82.
10. Solaro C, Brichetto G, Amato MP, Cocco E, Colombo B, D'Aleo G, et al. The prevalence of pain in multiple sclerosis: a multicenter crosssectional study. Neurology 2004;63(5):919-21.
11. Khan F, Pallant J. Chronic pain in multiple sclerosis: prevalence, characteristics, and impact on quality of life in an Australian community cohort. J Pain 2007;8(8):614-23.
12. Osterberg A, Boivie J, Thuomas KA. Central pain in multiple sclerosis - prevalence and clinical characteristics. Eur J Pain 2005;9:531-42.
13. Kwolek A, Śpiewak D. Ból w stwardnieniu rozsianym. Badania własne. Post Reh 1998;12:173-83.
14. Ehde DM, Osborne TL, Hanley MA, Jensen MP, Kraft GH. The scope and nature of pain in persons with multiple sclerosis. Multiple Scler 2006;12(5):629-38.
15. Solaro C, Trabucco E, Messmer Ucelli M. Pain and multiple sclerosis: pathophysiology and treatment. Curr Neurol Neurosci Rep 2013;13(1):320-9.
16. Truini A, Galeotti F, Le Cesa S, Di Rezze S, Biasiotta A, Di Stefano G, et al. Mechanisms of pain in multiple sclerosis: a combined clinical and neurophysiological study. Pain 2012;153:2048-54.
17. Siddall PJ, Cousins MJ. Neurobiology of pain. Int Anesthesiol Clin 1997;35(2):1-26.
18. Woolf CJ, Mannion RJ. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet 1999;353(9168):1959-64.
19. Stȩpień A, Domzał TM. Nowe wytyczne dotycza̧ce leczenia bólu neuropatycznego. Neurol Neurochir Pol 2010;44(5):437-42.
20. World Health Organization. International classification of functioning, disability, and health: ICF. Geneva: WHO; 2001.
21. Truini A, Barbanti P, Pozzilli C, Cruccu G. A mechanism-based classification of pain in multiple sclerosis. J Neurol 2013;260(2):351-67.
22. Beck RW, Gal RL. Treatment of acute optic neuritis: a summary of findings from the optic neuritis treatment trial. Arch Ophthalmol 2008;126:994-5.
23. Solaro C, Uccelli MM. Management of pain in multiple sclerosis: a pharmacological approach. Nat Rev Neurol 2011;7(9):519-27.
24. Truini A, Galeotti F, Cruccu G. Treating pain in multiple sclerosis. Expert Opin Pharmacother 2011;12(15):2355-68.
25. Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Multiple Scler 2000;6(3):192-3.
26. Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998;51(2):611-4.
27. Finnerup NB, Gottrup H, Jensen TS. Anticonvulsants in central pain. Expert Opin Pharmacother 2002;3(10):1411-20.
28. Dworkin RH, O'Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS, et al. Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 2007;132(3):237-51.
29. Podda G, Constantinescu CS. Nabiximols in the treatment of spasticity, pain and urinary symptoms due to multiple sclerosis. Expert Opin Biol Ther 2012;12(11):1517-31.
30. Zajicek JP, Hobart JC, Slade A, Barnes D, Mattison PG, on behalf of the MUSEC Research Group. Multiple sclerosis and extract of cannabis: results of the MUSEC trial. J Neurol Neurosurg Psychiatry 2012;83:1125-32.
31. Zajicek JP, Apostu VI. Role of cannabinoids in multiple sclerosis. CNS Drugs 2011;25(3):187-201.
32. Al-Araji AH, Oger J. Reappraisal of Lhermitte's sign in multiple sclerosis. Multiple Scler 2005;11:398-402.
33. Matthews WB. Paroxysmal symptoms in multiple sclerosis. J Neurol Neurosurg Psychiatry 1975;38(6):617-23.
34. Gutrecht JA, Zamani AA, Slagado ED. Anatomic-radiologic basis of Lhermitte's sign in multiple sclerosis. Arch Neurol 1993;50(8):849-51.
35. Kanchandani R, Howe GJ. Lhermitte's sign in multiple sclerosis: a clinical survey and review of the literature. J Neurol Neurosurg Psychiatry 1982;45(4):308-12.
36. Sakurai M, Kanazawa I. Positive symptoms in multiple sclerosis: their treatment with sodium channel blockers, lidocaine and mexiletine. J Neurol Sci 1999;162:162-8.
37. Shibasaki H, Kuroiwa Y. Painful tonic seizure in multiple sclerosis. Arch Neurol 1974;30:47-51.
38. Spissu A, Cannas A, Ferrigno P, Pelaghi AE, Spissu M. Anatomic correlates of painful tonic spasms in multiple sclerosis. Mov Disord 1999;14(2):331-5.
39. Ramirez-Lassepas M, Tulloch JW, Quinones MR, Snyder BD. Acute radicular pain as a presenting symptom in multiple sclerosis. Arch Neurol 1992;49(3):255-8.
40. Castro-Sanchez AM, Mataran-Penarrocha GA, Lara-Palomo I, Saavedra-Hernandez A, Arroyo-Morales M, Moreno-Lorenzo C. Hydrotherapy for the treatment of pain in people with multiple sclerosis: a randomized controlled trial. Evid Based Complement Alternat Med 2012;2012:1-8.
41. Miller L, Mattison P, Paul L, Wood L. The effects of transcutaneous electrical nerve stimulation (TENS) on spasticity in multiple sclerosis. Multiple Scler 2007;13 (4):527-33.
42. Love S, Coakham HB. Trigeminal neuralgia: pathology and pathogenesis. Brain 2001;124:2347-60.
43. Katusic S, Williams DB, Beard CM, Bergstralh EJ, Kurland LT. Epidemiology and clinical features of idiopathic trigeminal neuralgia and glossopharyngeal neuralgia: similarities and differences, Rochester, Minnesota, 1945-1984. Neuroepidemiology 1991;10:276-81.
44. Cruccu G, Biasiotta A, Di Rezze S, Fiorelli M, Galeotti F, Innocenti P, et al. Trigeminal neuralgia and pain related to multiple sclerosis. Pain 2009;143:186-91.
45. Mills RJ, Young CA, Smith ET. Central trigeminal involvement in multiple sclerosis using high-resolution MRI at 3T. Brit J Radiol 2010;83:493-8.
46. Gass A, Kitchen N, MacManus DG, Moseley IF, Hennerici MG, Miller DH. Trigeminal neuralgia in patients with multiple sclerosis: lesion localization with magnetic resonance imaging. Neurology 1997;49:1142-4.
47. Hooge JP, Redekop WK. Trigeminal neuralgia in multiple sclerosis. Neurology 1995;45:1294-6.
48. Minagar A, Sheremata WA. Glossopharyngeal neuralgia and MS. Neurology 2005;54:1368-70.
49. Ramsaransing G, Zwanikken C, De Keyser J. Worsening of symptoms of multiple sclerosis associated with carbamazepine. Brit Med J 2000;320:1113.
50. Stovner LJ, Hagen K, Jensen R, Katsarava Z, Lipton RB, Scher AI, et al. The global burden of headache a documentation of headache prevalence and disability worldwide. Cephalalgia 2007;27:193-210.
51. D'Amico D, La Mantia L, Rigamonti A, Usai S, Mascoli N, Milanese C, et al. Prevalence of primary headaches in people with multiple sclerosis. Cephalalgia 2004;24:980-4.
52. Nicoletti A, Patti F, Lo Fermo S, Liberto A, Castiglione A, Laisa P, et al. Headache and multiple sclerosis: a population-based case-control study in Catania, Sicily. Cephalalgia 2008;28:1163-9.
53. Putzki N, Pfriem A, Limmroth V, Yaldizil O, Tetteborn B, Diener HC, et al. Prevalence of migraine, tension-type headache and trigeminal neuralgia in multiple sclerosis. Eur J Neurol 2009;16:262-7.
54. Boneschi FM, Colombo B, Annovazzi P, Martinelli V, Bernasconi L, Solaro C, et al. Lifetime and actual prevalence of pain and headache in multiple sclerosis. Multiple Scler 2008;14:514-21.
55. Compston N, McAlpine D. Some aspects of the natural history of disseminated sclerosis. Q J Med 1952;21:135-67.
56. Freedman MS, Gray TA. Vascular headache: a presenting symptom of multiple sclerosis. Can J Neurol Sci 1989;16: 63-6.
57. Rolak LA, Brown S. Headaches and multiple sclerosis: a clinical study and review of the literature. J Neurol 1990;237:300-2.
58. Vacca G, Marano E, Brescia Morra V, Lanzillo R, De Vito M, Parente E, et al. Multiple sclerosis and headache co-morbidity. A case-control study. Neurol Sci 2007;28:133-5.
59. Warren S, Warren KG. Multiple sclerosis and associated diseases: a relationship to diabetes mellitus. Can J Neurol Sci 1981;8:35-9.
60. Gee JR, Chang J, Dublin AB, Vijayan N. The association of brainstem lesions with migraine-like headache: an imaging study of multiple sclerosis. Headache 2005;45: 670-7.
61. Tortorella P, Rocca MA, Colombo B, Annovazzi P, Comi G, Filippi M. Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neurol Sci 2006;244:137-41.
62. Ergün U, Ozer G, Sekercan S, Artan E, Kudiaki C, Ucler S, et al. Headaches in the different phases of relapsing-remitting multiple sclerosis: a tendency for stabbing headaches during relapses. Neurologist 2009;15: 212-6.
63. Kister I, Caminero AB, Monteith TS, Soliman A, Bacon TE, Kalina JT, et al. Migraine is comorbid with multiple sclerosis and associated with a more symptomatic MS course. J Headache Pain 2010;11(5):417-25.
64. Dooley MC, Foroozan R. Optic neuritis. J Ophthalmic Vis Res 2010;5:182-7.
65. Keltner JL, Johnson CA, Cello KE, Dontchev M, Gal RL, Beck RW. Visual field profile of optic neuritis: a final follow-up report from the optic neuritis treatment trial from baseline through 15 years. Arch Ophthalmol 2010;128:330-7.
66. Shams PN, Plant GT. Optic neuritis: a review. Int MS J 2009;16:82-9.
67. Rocca MA, Hickman SJ, Bo L, Agosta F, Miller DH, Comi G, et al. Imaging the optic nerve in multiple sclerosis. Multiple Scler 2005;11:537-41.
68. Opara J, Jaracz K, Brola W. Obcia̧zenie i jakość zycia opiekunów osób chorych na stwardnienie rozsiane. Neurol Neurochir Pol 2012;46(5):472-9.
69. Łabuz-Roszak B, Kubicka-Ba̧czyk K, Pierzchała K, Machowska-Majchrzak A, Skrzypek M. Zwia̧zek zmȩczenia z zaburzeniami snu, objawami depresyjnymi i lȩkowymi u chorych na stwardnienie rozsiane. Neurol Neurochir Pol 2012;46(4):309-17.